Vascular Access Guidelines & Clinical Practice Guidelines (CPGs)

The definitive index of vascular access clinical practice guidelines — INS Standards, CDC, IDSA, SHEA/IDSA, MAGIC, Joint Commission NPSG, CMS, and the AVA Clinical Practice Guidelines 2026 — with what each covers and when to apply it.

1 article Updated Jan 2026

Vascular access practice in the United States is governed by a layered framework of standards, clinical practice guidelines (CPGs), and regulatory requirements. No single document covers everything — safe, defensible practice means knowing which guideline answers which question and how they fit together. This hub indexes every major vascular access guideline, summarizes what each one covers, and links to the in-depth content on this site.


How the Guidelines Fit Together

TypeExamplesWhat it doesEnforceable?
Standard of practiceINS Infusion Therapy StandardsDefines the minimum competent level of infusion and vascular access practiceDefines the standard of care
Clinical practice guideline (CPG)AVA CPGs, IDSA, MAGICEvidence-graded recommendations for specific clinical questionsGuidance
Prevention guidelineCDC, SHEA/IDSA CompendiumBundled, evidence-based prevention strategies (e.g., CLABSI)Guidance / basis for regulation
Regulatory requirementJoint Commission NPSG, CMS CoPSurveyed, enforceable safety requirementsYes

INS Infusion Therapy Standards of Practice (8th ed., 2021)

The Infusion Nurses Society (INS) Standards are the foundational reference for infusion and vascular access practice. They define device selection, insertion, site assessment, dressing and securement, flushing and locking, dwell, and documentation. The Standards establish the Vessel Health and Preservation (VHP) approach and the osmolarity/pH thresholds that drive peripheral-versus-central decisions.

See the Vascular Access pillar for the VHP framework and device-selection thresholds.

The CDC guidelines (2011, with subsequent updates) are the backbone of CLABSI prevention. They are the evidence base for the insertion and maintenance bundles standard across US hospitals.

See CLABSI Prevention: Evidence-Based Bundle Framework.

The Infectious Diseases Society of America (IDSA) guidelines define the diagnostic criteria and management pathways for catheter-related and central line-associated bloodstream infection (CRBSI/CLABSI), including when to culture, when to remove, and how to treat.

SHEA/IDSA Compendium — Strategies to Prevent CLABSI

The SHEA/IDSA Compendium translates the evidence into prioritized, practical prevention strategies for acute care, distinguishing essential practices from additional approaches for facilities with persistent rates.

MAGIC — Michigan Appropriateness Guide for Intravenous Catheters

MAGIC (Chopra et al., 2015) provides RAND/UCLA-appropriateness ratings for device selection by indication and expected duration — the most cited framework for appropriate PICC use and reducing inappropriate placements.

See Evidence-Based Device Selection.

Joint Commission NPSG 07.04.01

The Joint Commission’s National Patient Safety Goal 07.04.01 requires organizations to implement evidence-based practices to prevent CLABSI, with documented insertion and maintenance bundle adherence assessed during survey.

CMS Conditions of Participation

CMS includes HAI prevention (including CLABSI) in its Conditions of Participation, with CLABSI rates publicly reported via Hospital Compare.


AVA Clinical Practice Guidelines 2026

The Association for Vascular Access (AVA) Adult Clinical Practice GuidelinesJournal of the Association for Vascular Access (JAVA), January Supplement 2026, Volume 31 — are the most comprehensive single CPG for the field, with evidence-graded recommendations from infrastructure and patient assessment through device selection, insertion, maintenance, and complication management.

Read the full guideline summary: AVA Clinical Practice Guidelines 2026


Putting Guidelines Into Practice

Frequently asked questions

What are the main vascular access guidelines?
The core vascular access clinical practice guidelines are the INS Infusion Therapy Standards of Practice (8th ed., 2021), the CDC Guidelines for the Prevention of Intravascular Catheter-Related Infections, the IDSA catheter-related infection guidelines, the SHEA/IDSA Compendium strategies to prevent CLABSI, the Michigan Appropriateness Guide for Intravenous Catheters (MAGIC), the Joint Commission NPSG 07.04.01, CMS Conditions of Participation, and the AVA Clinical Practice Guidelines (2026).
What is the difference between a guideline, a standard, and a clinical practice guideline (CPG)?
A standard (such as the INS Standards of Practice) defines the minimum competent level of practice. A clinical practice guideline (CPG) is a set of evidence-graded recommendations developed by a professional body to guide decisions for specific clinical questions. A regulatory requirement (Joint Commission NPSG, CMS CoP) is enforceable and surveyed. In practice, vascular access teams apply all three together.
Which guideline governs CLABSI prevention?
CLABSI prevention is primarily governed by the CDC intravascular catheter guidelines and the SHEA/IDSA Compendium, operationalized through insertion and maintenance bundles, and enforced through Joint Commission NPSG 07.04.01 and CMS public reporting. The INS Standards and AVA CPGs provide complementary device-selection and maintenance guidance.
What are the AVA Clinical Practice Guidelines?
The Association for Vascular Access (AVA) Clinical Practice Guidelines are comprehensive, evidence-graded recommendations across the full scope of vascular access — infrastructure, patient assessment, device selection, insertion, maintenance, and complication management — published in the Journal of the Association for Vascular Access (JAVA), January 2026 Supplement, Volume 31.

AVA Clinical Practice Guidelines

Association for Vascular Access (AVA) Adult Clinical Practice Guidelines — JAVA January Supplement 2026, Volume 31. Evidence-based recommendations for vascular access practice.